The Lyme disease spirochaete, Borrelia burgdorferi, can invade and persistently infect its hosts' connective tissues. We now demonstrate that B. burgdorferi adheres to the extracellular matrix component laminin. The surface-exposed outer-membrane protein ErpX was identified as having affinity for laminin, and is the first laminin-binding protein to be identified in a Lyme disease spirochaete. The adhesive domain of ErpX was shown to be contained within a small, unstructured hydrophilic segment at the protein's centre. The sequence of that domain is distinct from any previously identified bacterial laminin adhesin, suggesting a unique mode of laminin binding.
INTRODUCTION
Borrelia burgdorferi, the Lyme disease spirochaete, is capable of infecting immunocompetent humans and other vertebrates for extensive periods, even for the host's lifetime. B. burgdorferi is an extracellular organism, frequently found associated with its hosts' connective tissues (Barthold et al., 1991 (Barthold et al., , 1992a (Barthold et al., , b, 1993 Cabello et al., 2007; Cadavid et al., 2003; De Koning et al., 1987; Defosse et al., 1992; Franz et al., 2001; Häupl et al., 1993; Kornblatt et al., 1984; Pachner et al., 1995) . B. burgdorferi has been demonstrated to possess affinity for various host extracellular matrix (ECM) components, such as type 1 collagen, fibronectin and decorin (Cabello et al., 2007; Grab et al., 1998; Guo et al., 1995; Probert & Johnson, 1998; Zambrano et al., 2004) . Several borrelial outersurface proteins have been identified that exhibit affinities for some of those host components (Fischer et al., 2006; Guo et al., 1995; Probert & Johnson, 1998) .
All examined infectious Lyme disease spirochaete isolates naturally contain between 6 and 10 distinct, but homologous, DNA elements called cp32s (Casjens et al., 2006; Stevenson et al., 2001 Stevenson et al., , 2006 . Most cp32 elements are circular episomes approximately 32 kb in size. However, some naturally occurring mutant cp32 family members have been identified, such as the lp56 element of B. burgdorferi type strain B31, which consists of an entire cp32 integrated into an unrelated linear replicon (Casjens et al., 2000) . Each cp32 contains a mono-or bicistronic erp locus, which generally varies in sequence between the different cp32s carried by an individual bacterium . Moreover, different bacterial strains often contain unique erp genes. Erp proteins are surface-exposed outer-membrane lipoproteins that are highly expressed during mammalian infection but generally repressed during colonization of the tick vector (Das et al., 1997; El-Hage et al., 2001; Gilmore et al., 2001; Hefty et al., 2002; Lam et al., 1994; Liang et al., 2002; McDowell et al., 2001; Miller et al., 2003 Miller et al., , 2005 Skare et al., 1999) .
To date, functions have been ascribed to only a few borrelial Erp proteins, but are consistent with expression of this family of proteins during vertebrate infection. Several closely related (.85 % amino acid sequence identities) Erp proteins bind both mammalian factor H and plasminogen/ plasmin (Alitalo et al., 2002; Brissette et al., 2009; Hellwage et al., 2001; Kraiczy et al., 2003 Kraiczy et al., , 2004 Metts et al., 2003; Stevenson et al., 2002) . One member of that group, ErpP (also called BbCRASP-3), binds another, distinct human serum protein, factor H-related protein 1 (FHR-1) (Haupt et al., 2007) . At least one other Erp protein adheres to an unknown component(s) of murine endothelium (Antonara et al., 2007) .
We now present results of the first studies on interactions between B. burgdorferi and mammalian laminin, a major component of vertebrate basement membranes and many other connective tissues (Colognato & Yurchenco, 2000; Freinkel & Woodley, 2001; Sasaki et al., 2004) . Such interactions may facilitate migration of B. burgdorferi through extracellular matrices and/or assist in long-term colonization of laminin-containing host tissues. B. burgdorferi was found to produce several membrane-associated laminin-binding proteins, including the ErpX outermembrane lipoprotein.
METHODS
Bacteria. B. burgdorferi strain B31 is the species type strain (Johnson et al., 1984) . The complete genome sequence of a non-clonal subculture of strain B31, called B31-MI, has been determined (Casjens et al., 2000; Fraser et al., 1997) . A total of 10 distinct erpbearing cp32 family members have been identified in strain B31, as follows: three separate, identical copies of erpAB on cp32-1, cp32-5 and cp32-8 (formerly known as erpAB, erpIJ and erpNO, respectively); erpCD on cp32-2; erpG on cp32-3; erpHY on cp32-4; erpK on cp32-6; erpLM on cp32-7; erpPQ on cp32-9; and erpX on lp56 (Casjens et al., , 2000 Stevenson et al., 1996) . The present studies all used an infectious clone derived from the sequenced culture, named B31- , that contains all the naturally occurring DNA elements of B31-MI .
To date, the complete erp contents of four additional strains of Lyme disease spirochaetes have been determined: B. burgdorferi strains N40, 297, Sh-2-82 and BL206 (Akins et al., 1999; and our unpublished results) . Strains B31 and BL206 are nearly identical to each other, and have been classified as members of intergenic spacer type (IGS) group 1, as determined by sequence analysis of the 16S-23S rRNA gene spacer region (Bunikis et al., 2004; Terekhova et al., 2006; Wang et al., 2001; and our unpublished results) . Strains 297 and Sh-2-82 are also nearly identical to each other, and are members of IGS group 2 (Akins et al., 1999; Bunikis et al., 2004; . Strain N40 is largely distinct genetically from the other analysed strains, and is a member of IGS group 9 (Bunikis et al., 2004; . Sequences of those strains' erp genes and their encoded proteins were compared with those of strain B31 to identify similarities using CLUSTAL_X (Thompson et al., 1997) with default parameter settings.
B. burgdorferi was cultured in Barbour-Stoenner-Kelly II medium (BSK-II) at 34 uC (Zückert, 2007) . Cultures (100 ml) used for bacterial cell lysates were harvested at mid-exponential phase (approx. 10 7 bacteria ml 21 ) and fractionated using Triton X-114 (Pryde, 1986 ). This method yields three fractions from the bacteria: a detergentsoluble fraction primarily consisting of outer-membrane components, an aqueous fraction consisting of periplasmic components, and a pellet that primarily consists of inner-membrane and cytoplasmic components (Cunningham et al., 1988; El-Hage et al., 2001; Radolf et al., 1988) . The detergent-soluble, outer-membrane-enriched fraction was used for adhesin analyses.
Interactions between intact B. burgdorferi and laminin. Glass microscope slides were washed with deionized water, then coated by overnight incubation with 5 mg ml 21 Engelbreth-Holm-Swarm (EHS) mouse sarcoma laminin (Sigma-Aldrich) in PBS. Mice and other rodents are natural reservoir hosts of B. burgdorferi, particularly so in the north-eastern USA, where strain B31 was isolated (Lane et al., 1991) . Control slides were coated similarly with bovine serum albumin (BSA). The following day, slides were washed three times with PBS, then blocked by incubation with 3 % (w/v) BSA for 2 h at room temperature. Cultured B31-MI-16 (10 7 bacteria ml
21
, midexponential phase) were harvested by centrifugation, washed once with PBS and resuspended in PBS to the original volume. Slides were covered with suspended bacteria, incubated at 37 uC for 2 h, then gently washed 10 times with PBS. Bacteria were visualized by darkfield microscopy. Numbers of adherent bacteria observed in ten 2006 fields per slide were counted.
B. burgdorferi-laminin interactions were quantified by ELISA as follows. Maxisorp 96-well plates (Nalge-Nunc) were coated overnight with 10 mg ml 21 EHS laminin (Sigma-Aldrich) in 50 mM NaHCO 3 (pH 9.6) at 4 uC (Stevenson et al., 2007) . Plates were brought to room temperature and washed once with PBS+0.5 % (v/v) Tween 20 (PBS-T). Wells were blocked for 2 h at room temperature with 2 % (w/v) BSA in PBS, then washed three times with PBS-T. Cultured B31-MI-16 (10 7 bacteria ml 21 , mid-exponential phase) were harvested, washed once with PBS and resuspended to the original volume. Aliquots (100 ml) of bacteria were added to each well and incubated for 2 h at 37 uC. Wells were washed three times with PBS-T, then incubated for 1 h at room temperature with rabbit antiserum raised against a membrane-enriched extract of cultured B. burgdorferi strain B31, diluted 1 : 10 000 in PBS . Plates were washed three times with PBS-T, then incubated for 1 h at room temperature with horseradish-peroxidase-conjugated anti-rabbit IgG (GE Healthcare), diluted 1 : 10 000. Wells were again washed three times with PBS-T, 100 ml per well tetramethylbenzidine substrate (SigmaAldrich) was added, then reactions were stopped by addition of 1 M H 2 SO 4 , 100 ml per well. Absorbance was read at 450 nm using a Spectramax plate reader using SoftMax Pro (Molecular Devices).
The effects of soluble recombinant ErpX and mutant proteins upon laminin binding by live B. burgdorferi were examined by ELISA as described above, with one additional step. After washing the laminincoated wells, a 100 ml aliquot of a recombinant protein or BSA (initial concentration 10 mg ml 21 ) was added to each well, followed by incubation at 37 uC for 30 min. Bacteria were then added directly to each well. Each assay was replicated at least six times.
Statistical analyses were performed using Student's t-test assuming unequal variances.
Recombinant proteins. Most of the polyhistidine-tagged, fulllength recombinant Erp proteins used in this work have been described earlier Stevenson et al., 1998) . All recombinant proteins contained amino-terminal tags, with the Erp segment beginning with that protein's first amino acid following the conserved cysteine lipidation site. Expression plasmids for recombinant ErpA, ErpC, ErpL, ErpP, ErpQ, ErpY and ErpX were based on pET15b (Novagen), plasmids producing recombinant ErpG, ErpK and ErpM were based on pProEX-1 (Life Technologies), and that for recombinant ErpB was based on pET100 (Invitrogen). Two additional constructs, encoding carboxy-terminally truncated recombinant ErpX proteins, were produced from B31-MI-16 total genomic DNA using oligonucleotide primer pairs 59-CACCAAGATTGA-TGCAACTGGTAAAG-39 plus 59-AATTTCTTAAAATTTAGAA-TTG-39 or 59-CACCAAGATTGATGCAACTGGTAAAG-39 plus 59-TTCTTAAACCTTTTCTAATCCTG-39, and cloned into pET200 (Invitrogen). Further constructs encoding additionally amino-or carboxy-terminally truncated recombinant ErpX proteins were produced from those pET200-based clones, using sequence-overlap extension PCR mutagenesis (Ho et al., 1989) to either delete sections of the erpX open reading frame or introduce premature stop codons. A plasmid encoding recombinant Erp26 was produced from a plasmid clone of the strain N40 locus , using pET200 as its basis. Inserts of all recombinant plasmids were entirely sequenced on both strands to ensure that no undesired mutations had occurred during PCR or cloning procedures.
Recombinant proteins were expressed in Escherichia coli Rosetta(DE3)pLysS (Novagen), upon induction with IPTG. Induced E. coli were harvested, lysed by sonication, and debris cleared by centrifugation. Recombinant proteins were purified from cleared lysates using MagneHis nickel-conjugated magnetic beads (Promega). Concentrations of protein preparations were determined by bicinchoninic acid assay as compared with defined stock concentrations of BSA (Pierce).
Ligand-affininty blot analysis of laminin binding. Immediately prior to use, all apparatus used in these analyses was thoroughly washed with detergent and rinsed with deionized water, since laminin from human skin was found to be a common contaminant of laboratory equipment. Commercially obtained protein molecular mass standards were also found to be frequently contaminated with laminin or substances able to bind laminin, so at least one empty lane was left between the molecular mass standards and the proteins being examined, to avoid blurring of blot signals. BSA was used to block membranes after transfer, since the more commonly used blocking agent non-fat dried milk contains laminin, which obscures results of these analyses.
Recombinant proteins, Triton X-114 outer-membrane fractions, or control protein BSA were suspended in SDS gel loading buffer [125 mM Tris (pH 6.8), 20 % (v/v) glycerol, 4 % (w/v) SDS, 10 % (v/v) b-mercaptoethanol], and heated in a boiling water bath for approximately 1 min. An aliquot (approx. 1 mg) of each protein was loaded into wells of polyacrylamide gels (without added SDS), then subjected to electrophoresis. Proteins were electrotransferred to nitrocellulose membranes, then blocked overnight at 4 uC with 5 % (w/v) BSA in Tris-buffered saline-Tween 20 [TBS-T; 20 mM Tris (pH 7.5), 150 mM NaCl, 0.05 % (v/v) Tween 20]. Membranes were next washed with TBS-T, and incubated for 1 h at room temperature in 13 mg ml 21 EHS laminin (Sigma-Aldrich) in TBS-T. After extensive washing with TBS-T, membranes were incubated for 1 h at room temperature in affinity-isolated rabbit anti-EHS laminin polyclonal antiserum (Sigma-Aldrich), diluted 1 : 2500 in TBS-T. Membranes were again washed with TBS-T, then incubated for 1 h at room temperature with horseradish-peroxidase-conjugated donkey antirabbit Ig antibody (GE Healthcare), diluted 1 : 5000 in TBS-T. After a final series of washes with TBS-T, bound antibodies were detected using SuperSignal West Pico enhanced chemiluminescence substrate (Pierce). Each recombinant protein was assayed at least twice. 
RESULTS

B. burgdorferi adheres to laminin
As noted in the Introduction, Lyme disease spirochaetes are frequently found associated with host ECM during vertebrate infection. Since laminin is a major component of basement membranes and other mammalian ECMs (Freinkel & Woodley, 2001; Sasaki et al., 2004) , the ability of B. burgdorferi to adhere to laminin was examined in detail. Intact, live B. burgdorferi were observed to adhere to laminin-coated microscope slides in significantly greater numbers than to BSA-coated slides (Fig. 1A) . Spirochaetelaminin interactions were further quantified through use of an ELISA-based method, again demonstrating that B. burgdorferi exhibits a marked affinity for laminin (Fig. 1B) .
The specificity of B. burgdorferi-laminin interactions was further analysed by ligand-affinity blot analyses using purified laminin and an outer-membrane fraction of B. burgdorferi. This technique indicated that cultured B. burgdorferi strain B31 produced three proteins with detectable affinities for laminin, having approximate molecular masses of 40 and 50 kDa (Fig. 2) .
ErpX binds mammalian laminin
Studies by our laboratories and others have demonstrated that all B. burgdorferi erp genes so far examined are expressed during mammalian infection (our unpublished results; Crother et al., 2004; Liang et al., 2002; Miller et al., 2005; . Noting that the lamininbinding outer-membrane proteins detected in Fig. 2 are of sizes similar to some Erp proteins (Casjens et al., 2000; Stevenson et al., 1998 Stevenson et al., , 2006 , we hypothesized that one or more of the borrelial laminin-binding proteins may be an Erp protein. To explore that possibility, recombinant Erp proteins were produced from all the erp gene sequences carried by B. burgdorferi strain B31. Equal amounts of each protein were then subjected to ligand-affininty blot analyses to determine their abilities to bind laminin. BSA was also included, as a negative control to demonstrate that ligand binding was not due to non-specific protein-protein interactions. As described below, most of the recombinant Erp proteins did not bind laminin, and therefore also served as controls for specificity of laminin binding.
Of the strain B31-derived Erp proteins, only recombinant ErpX bound laminin with a detectable affinity (Fig. 3A) . Native, lipidated ErpX migrates in SDS-PAGE with an apparent molecular mass of approximately 45-50 kDa (ElHage et al., 2001; Stevenson et al., 1998) , and was probably the larger laminin-binding protein observed in Fig. 2 . Several of the other tested recombinant Erp proteins (ErpA, ErpC, ErpL, ErpP, ErpQ, ErpY) were produced using the same cloning vector as was ErpX, and all included the same amino-terminal tag, so the inabilities of those other recombinant proteins to bind laminin demonstrated that laminin binding by recombinant ErpX was not due to its polyhistidine tag. The erpX gene sequence is distinct from all the other erp genes of B. burgdorferi strain B31 . Of the strain B31 Erp proteins, ErpX shares the highest degree of similarity with ErpQ protein (see Supplementary Fig. S1 , available with the online version of this paper), which did not detectably bind laminin, indicating that the laminin-binding region(s) of ErpX is distinct from any sequence found in ErpQ.
The complete erp gene sequences of several additional strains of the Lyme disease spirochaete have been determined. Of all the known borrelial erp genes, the strain N40 erp26 gene shares the highest degree of similarity with the strain B31 erpX gene (Fig. S1 and Stevenson et al., 2006) . Due to that similarity, recombinant N40 Erp26 protein was produced and assayed for ability to bind laminin. However, recombinant Erp26 was not able to bind laminin at detectable levels (Fig. 3B) . Thus, the lamininbinding domain(s) of ErpX is also distinct from any sequence within Erp26. Studies described below determined that the laminin-binding domain of ErpX consists of sequences unlike any found in either the N40 Erp26 or B31 ErpQ proteins, consistent with the results of these ligand-affininty analyses.
Mapping the laminin-binding domain of ErpX
Truncated variants of ErpX were produced to narrow down the region of that protein involved with binding of laminin. A distinctive characteristic of ErpX is a fivefold repeat of the 5 amino acid sequence aspartate-alanine-threonineglycine-lysine near the protein's amino terminus (Fig. 4A and Fig. S1 ). However, truncated variants of ErpX lacking the repeated amino acid sequence, such as rErpX3 and rErpX5, did not show any appreciable differences in laminin binding, indicating that the amino acid repeat region does not play a direct role in adhesion to laminin (Figs 4A and 5A) . Additional amino-and carboxyterminally truncated variants of ErpX were produced and assessed for ability to bind laminin. Truncated proteins rErpX3 through rErpX12 all bound laminin with the same apparent affinities as did the full-length, wild-type rErpX protein (Figs 4A and 5A, and data not shown).
Loss of ligand binding was observed upon truncation of ErpX to the 112 residue rErpX16 (Figs 4 and 5B). Recombinant protein rErpX14, consisting of 90 amino acids nested within rErpX16, was similarly unable to bind laminin. However, protein rErpX15, which contains only 84 amino acids, retained laminin-binding activity. Since the sequences of rErpX15 and rErpX16 overlap (Fig. 4A) , these results indicate that the carboxy-terminal 32 amino acids of rErpX15 include residues critical for binding of laminin.
Following the result of studies with rErpX15 and rErpX16, protein rErpX17 was produced, consisting of the entire ErpX sequence except for 55 central amino acids (Fig. 4) . Consistent with the ability of rErpX15 to bind laminin and the inabilities of rErpX14 and rErpX16 to bind that ligand, rErpX17 did not bind laminin at detectable levels (Fig. 5C) . Full-length rErpX and several fragments were analysed for abilities to interfere with adhesion of B. burgdorferi to laminin. Consistent with the above-described ligandaffininty blot analyses, rErpX, rErpX-12, rErpX-13 and rErpX-15 all reduced B. burgdorferi adherence to laminin by 60-70 % (Fig. 6) . Protein rErpX-17 inhibited binding by approximately 20 %, suggesting that this protein retains some, otherwise undetectable affinity for laminin. Addition of the control protein, BSA, did not influence lamininbinding by the spirochaetes. As are all Erp proteins, ErpX is a highly charged molecule, with the full-length, mature protein containing 18 % glutamate, 9 % aspartate and 19 % lysine residues and having a predicted pI of 4.9. The central, laminin-binding region defined by the deletion within rErpX17 has a predicted pI of 11.1 and consists of 20 % glutamate, 4 % aspartate, 29 % lysine, 18 % glutamine and 15 % arginine residues (Fig. 4A) . Modelling analyses predicted that this central region is largely disordered (Fig. 4B) . The flanking sections of the full-length ErpX protein possess more structured natures, which could serve to stabilize or orient the protein's middle, laminin-binding region. Neither BLASTP nor PSI-BLAST detected similarities between the laminin-binding region of ErpX and any previously identified predicted protein. Likewise, PHYRE analyses did not predict either the central region or the full-length ErpX to have similarities with any known protein structure. ErpX appears to represent a novel type of bacterial laminin adhesin.
DISCUSSION
Lyme disease spirochaetes reside extracellularly during vertebrate infection. Several previous studies found that B. burgdorferi interacts with constituents of host ECM and cell-surface components. The present studies appear to be the first to demonstrate that B. burgdorferi adheres to laminin. Analyses of outer-membrane-enriched fractions of the cultured B. burgdorferi type strain B31 indicated that it produces three proteins with detectable affinities for laminin. We determined that the surface-exposed lipoprotein ErpX is a laminin-binding protein, and mapped its ligand-binding site to a short, unstructured region in the centre of the protein. Serological, RNA array and genespecific Q-RT-PCR analyses have all indicated that B. burgdorferi produces ErpX during mammalian infection (our unpublished results; Liang et al., 2002; Skare et al., 1999; Stevenson et al., 1998) . Thus, ErpX is appropriately poised on the borrelial outer surface to interact with host laminin, and we hypothesize that this bacterial protein contributes to invasion and/or long-term colonization of host tissues. Prior studies indicated that B. burgdorferi strains which lack lp56 (and are therefore erpX deficient) (Stevenson et al., 1998) : note that rErpX-5 migrated at a rate suggestive of a molecular mass greater than rErpX-3, even though rErpX-5 is actually the smaller protein. are still able to infect mice (Purser & Norris, 2000) , which may be due to binding of additional host ECM components by other borrelial surface proteins or to the redundancy of laminin-binding proteins produced by B. burgdorferi (see Fig. 2 ). Preliminary analyses of the other laminin adhesins with apparent molecular masses of 40 kDa suggest them to be members of the chromosomally encoded Bmp (p39) protein family (our unpublished results). Complete characterization of the other lamininbinding proteins is under way, with the goals of defining their mechanisms of ligand adhesion and producing mutant bacteria deficient in all laminin adhesins for mouse and tick infection studies.
There are no apparent similarities between ErpX and the known laminin-binding proteins of the spirochaetes Leptospira interrogans (Barbosa et al., 2006; Stevenson et al., 2007) , Treponema pallidum (Cameron, 2003; Cameron et al., 2005) or T. denticola (Edwards et al., 2005) , nor of any other organism, suggesting that ErpX adhesion to laminin may occur through a novel mechanism. The predicted disordered nature of the laminin-binding region of ErpX is reminiscent of the fibronectin-binding domain of the B. burgdorferi BBK32/Fbp/p47 protein, in which the binding site consists of a disordered sequence of amino acids which moulds itself around the ligand (Kim et al., 2004) .
One striking feature of ErpX is the fivefold reiterated 5 amino acid sequence near the amino terminus. Our studies demonstrated that this sequence is not directly involved with laminin binding. The directly repeated sequences of erpX presumably arose through either cross-fork slippage or recombination events (Lovett, 2004) . It is significant that this direct repeat involves a multiple of 3 bp, such that the reiterations did not alter the reading frame, and indicating that this repeat element cannot be involved with phase variation as occurs in bacteria such as Neisseria gonorrhoeae or Haemophilus influenzae. We also observed that the erpX genes of B. burgdorferi strains B31 and BL206 are identical (our unpublished results). As strain BL206 was isolated from nature 16 years after strain B31, and must have infected numerous vertebrate and tick hosts since the two strains shared a common ancestor, this direct repeat mutation appears to be highly stable. A possible function for the repeated amino-terminal motif of ErpX is suggested from studies of other bacterial adhesins: repeated amino acid sequences near the membrane anchor can provide distance between adhesive domains and the bacterial cell surface, and the greater the number of repeats, the further the adhesin extends into the environment (Patti et al., 1994; van Belkum, 1999 ).
In conclusion, we have determined that the B. burgdorferi outer-surface lipoprotein ErpX binds mammalian laminin, through a protein motif not previously recognized in other bacterial laminin adhesins. No other Erp proteins of strain B31 bound laminin, nor did the Erp26 protein of strain N40, and the functions of most of those proteins remain a mystery. However, the Lyme disease spirochaete produces at least two other laminin-binding proteins, neither of which is an Erp protein. It is possible that dissimilarities among the repertoires of Erp and other proteins produced by different B. burgdorferi strains may play roles in the variations in infectivity observed among isolates (Balmelli & Piffaretti, 1995; Liveris et al., 2002; Seinost et al., 1999; Shih et al., 1992; Terekhova et al., 2006; van Dam et al., 1993; Wang et al., 2002) . Similarly, differences in amino acid sequences and modifications to host ECM components such as laminin may contribute to the variations among borreliae in their abilities to efficiently infect different host species (Kurtenbach et al., 2006) . Further characterization of borrelial adhesins and examination of interactions between these bacterial proteins and host tissues will address those hypotheses, providing insight into the pathogenic properties of Lyme disease spirochaetes. Such information could direct development of therapeutic treatments that block adhesin-ECM interactions or disrupt production of adhesins associated with mammalian infection.
